• 2025

  Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma

  Sang Yean Kim, Jin Woong Ha, Min Jeong Na, Soyoung Jeon, Jung Hwan Yoon, Won Sang Park, Suk Woo Nam

  Exp. Mol. Med. 02 June 2025
  doi: 10.1038/s12276-025-01459-4

• 2024

  The roles and mechanisms of coding and noncoding RNA variations in cancer

  Sang Yean Kim, Min Jeong Na, Sungpil Yoon, Eunbi Shin, Jin Woong Ha, Soyoung Jeon and Suk Woo Nam

  Exp. Mol. Med., 02 September 2024 | https://doi.org/10.1038/s12276-024-01307-x

• 2023

  ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.

  Kim HS, Na MJ, Son KH, Yang HD, Kim SY, Shin E, Ha JW, Jeon S, Kang K, Moon K, Park WS, Nam SW.

  Exp. Mol. Med., Published: 04 January 2023 | https://doi.org/10.1038/s12276-022-00916-8

• 2022

  Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma.

  Eun JW, Jang JW, Yang HD, Kim J, Kim SY, Na MJ, Shin E, Ha JW, Jeon S, Ahn YM, Park WS, Nam SW.

  J Clin Med. 2022 Apr 11;11(8):2128. doi: 10.3390/jcm11082128.

• 2022

  hnRNPC induces isoform shifts in miR-21-5p leading to cancer development.

  Park S, Yang HD, Seo JW, Nam JW, Nam SW.

  Exp Mol Med. 2022 Jun;54(6):812-824. doi: 10.1038/s12276-022-00792-2. Epub 2022 Jun 21.

• 2021

  SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.

  Kim SY, Shen Q, Son K, Kim HS, Yang HD, Na MJ, Shin E, Yu S, Kang K, You JS, Yu KR, Jeong SM, Lee EK, Ahn YM, Park WS, Nam SW.

  Oncogene. 2021 Jul;40(28):4652-4662. doi: 10.1038/s41388-021-01875-6. Epub 2021 Jun 17.PMID: 341406